Drug Enforcement Administration 2019 – Federal Register Recent Federal Regulation Documents

Results 201 - 208 of 208
Importer of Controlled Substances Application: Chattem Chemicals
Document Number: 2019-01512
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC
Document Number: 2019-01510
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Kinetochem, LLC
Document Number: 2019-01509
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials, Inc.
Document Number: 2019-01507
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-01502
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-01501
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as Schedule II Controlled Substances; Correction
Document Number: 2019-01470
Type: Rule
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
On June 29, 2010, the Drug Enforcement Administration (DEA) placed the fentanyl immediate precursor chemical ``4-anilino-N- phenethyl-4-piperidine,'' (CASRN 21409-26-7) into Schedule II of the Controlled Substances Act. It has come to DEA's attention that the drug name listed in the final rule contained a minor error and the drug name should have been ``4-anilino-N-phenethylpiperidine (ANPP).'' This document corrects that listing in the Code of Federal Regulations. Because this change is ministerial, the DEA has determined for good cause that public notice and comment is unnecessary under the Administrative Procedure Act (APA) and is implementing this change by means of a final rule without notice and comment.
Schedules of Controlled Substances: Placement of MAB-CHMINACA in Schedule I
Document Number: 2019-00254
Type: Rule
Date: 2019-01-29
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places N-(1-amino-3,3- dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (MAB-CHMINACA; ADB-CHMINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle MAB-CHMINACA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.